Pharmacists expanded role in providing care for opioid use disorder during COVID-19: A qualitative study exploring pharmacists’ experiences
- 10 January 2022
- journal article
- research article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 232, 109303
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Qualitative exploration of the education and skill needs of community pharmacists in Saskatoon concerning substance use disorderCanadian Pharmacists Journal / Revue des Pharmaciens du Canada, 2019
- The North American Opioid Experience and the Role of Community PharmacyJournal of Public Health Management & Practice, 2018
- Management of opioid use disorders: a national clinical practice guidelineCanadian Medical Association Journal, 2018
- Pharmacists as accessible primary health care providers: Review of the evidenceCanadian Pharmacists Journal / Revue des Pharmaciens du Canada, 2018
- Harm reduction principles for healthcare settingsHarm Reduction Journal, 2017
- The State of Opioid Agonist Therapy in Canada 20 Years after Federal OversightThe Canadian Journal of Psychiatry, 2017
- Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: Systematic reviewDrug and Alcohol Dependence, 2013
- Factors influencing pharmacy services in opioid substitution treatmentDrug and Alcohol Review, 2013
- Pharmacists and Harm Reduction: A Review of Current Practices and AttitudesCanadian Pharmacists Journal / Revue des Pharmaciens du Canada, 2012
- Methadone as Social ControlQualitative Health Research, 2012